Repurposing the Antibiotic Tigecycline to Inhibit Tumor Growth and Hormone Secretion in Somatotroph Pituitary Neuroendocrine Tumors
Zhiqian Yang, Yang Liu, Dapeng Wu, Bin Xu, Shengfa Zeng, Wei Zhang · 2026
Read Repurposing the Antibiotic Tigecycline to Inhibit Tumor Growth and Hormone Secretion in Somatotroph Pituitary Neuroendocrine Tumors by Zhiqian Yang, Yang Liu, Dapeng Wu, Bin Xu, Shengfa Zeng, Wei Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13291717.txt.
Description
Zhiqian Yang and co-authors report 2026 laboratory work testing whether the antibiotic tigecycline can slow somatotroph pituitary tumors. They used the rat GH3 cell line, which models growth-hormone-secreting pituitary neuroendocrine tumors. Cells received tigecycline doses from 6.25 to 100 micromolar, and the team tracked viability, spheroid growth, cell death, and hormone output.
Tigecycline curbed cell growth in a dose- and time-dependent way and also held back three-dimensional spheroid growth. Treated cells stalled in the G0/G1 phase, showed weaker Akt/mTOR signaling, and died through the intrinsic apoptosis pathway. The drug also cut growth hormone production inside the cells and its release outside them. The authors offer these findings as early support for testing tigecycline against this tumor type.
Catalog record
| CREATOR | Zhiqian Yang, Yang Liu, Dapeng Wu, Bin Xu, Shengfa Zeng, Wei Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 24136 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |